FOXO4-DRI Peptide

$250.00

Product Classification

Classified as a senolytic research peptide

Description

FOXO4-DRI is a peptide designed to selectively disrupt FOXO4-p53 interactions in senescent cells, enabling apoptosis and clearance of senescent cell populations in preclinical models

Specifications

  • Molecular Type: Senolytic research peptide
  • Mechanism: FOXO4-p53 interaction disruption

Research Notes

  • Senolytics: preclinical studies report clearance of senescent cells.
  • Aging Research: investigated in tissue regeneration and lifespan models.
  • Apoptosis Pathways: induces targeted apoptosis in senescent cells via p53.
  • Regenerative Medicine: interest in organ/tissue repair applications.
Regulatory Statement

For research use only. Not for human or animal consumption.

Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent disease

SKU: N/A Category:

Additional information

Strength

10mg, 2mg

Reviews

There are no reviews yet.

Be the first to review “FOXO4-DRI Peptide”

Your email address will not be published. Required fields are marked *